Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Spironolactone Therapy in Chronic Stable Right HF Trial

NCT03344159 is registered in ClinicalTrials.gov with Ottawa Heart Institute Research Corporation as lead sponsor.

NCT NCT03344159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03344159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Spironolactone Therapy in Chronic Stable Right HF Trial
Lead sponsor
Ottawa Heart Institute Research Corporation
Phase
Phase 4
Overall status
Completed
Start date
April 1, 2018
Completion date
May 1, 2024
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiomyopathy right ventricular, chronic right-sided heart failure, pulmonary arterial hypertension, pulmonary hypertension, primary, 2, pulmonary hypertension, primary, 3, pulmonary hypertension, primary, 4